Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

Completed

• Conditions: Kidney Cancer

• Registration Number: NCT05461027
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-01
• Study First Submitted: 2022-07-12
• Study First Submitted QC: 2022-07-12
• Study First Posted: 2022-07-15
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-24
• Last Update Posted: 2024-12-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery	Files analysed retrospectively from January 01, 2018 to December 31, 2021 will be examined

Trial Locations

Locations (1)

Service d'Imagerie Interventionnelle - CHU de Strasbourg - France; 🇫🇷 Strasbourg, France